---
title: "Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293662324.md"
description: "California-based Heartflow, a pioneer in AI solutions for coronary artery disease, is set to unveil its financial performance for Q2 2026 post-market closing on August 13, 2026. Traded as HTFL on Nasdaq, the company will conduct a conference call at 1:30 p.m. PT / 4:30 p.m. ET on the same day to delve into the financial outcomes. The announcement signifies a crucial juncture for investors and industry enthusiasts keen on Heartflow's status and trajectory in the realm of CAD technology."
datetime: "2026-07-23T20:02:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293662324.md)
  - [en](https://longbridge.com/en/news/293662324.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293662324.md)
generator: "portal-rs"
---

# Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026

California-based Heartflow, a pioneer in AI solutions for coronary artery disease, is set to unveil its financial performance for Q2 2026 post-market closing on August 13, 2026. Traded as HTFL on Nasdaq, the company will conduct a conference call at 1:30 p.m. PT / 4:30 p.m. ET on the same day to delve into the financial outcomes. The announcement signifies a crucial juncture for investors and industry enthusiasts keen on Heartflow's status and trajectory in the realm of CAD technology.

### Related Stocks

- [HTFL.US](https://longbridge.com/en/quote/HTFL.US.md)

## Related News & Research

- [Heartflow CEO John C.M. Farquhar sells 32,676 common shares for $1.47 million](https://longbridge.com/en/news/296540340.md)
- [Heartflow CEO John C.M. Farquhar sells 15,560 common shares for $607,893.60](https://longbridge.com/en/news/296276095.md)
- [09:35 ETMemorial Brings the Future of Heart Imaging to South Florida](https://longbridge.com/en/news/296364381.md)
- [Voltalia updates financial calendar with half-year 2026 results release](https://longbridge.com/en/news/296937967.md)
- [10:31 ETLiver Cirrhosis Market to Expand Significantly Through 2036, Driven by Emerging Therapies and Increasing Disease Burden | DelveInsight](https://longbridge.com/en/news/296802956.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**